跳至主要内容
临床试验/NCT04793529
NCT04793529已完成不适用

Is Involucrin Has a Role in Verruca Vulgaris? A Clinical and Immunohistochemical Study

Benha University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
Resolution of verrucae

研究概览

简要总结

Vitamin D3 plays important role in keratinocyte differentiation and had been used recently in verruca vulgaris. Aim of the work: To assess the expression of involucrin in verrucae vulgaris before and after injection of vitamin D3. Subjects and Methods: This study included 60 patients with verrucae vulgaris subjected to intralesional injection of vitamin D3 at three weeks interval for a maximum of five sessions. Immunohistochemical assessment of involucrin was done before and after injection and compared to skin biopsies from 30 healthy individuals

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Patients with a past history of allergic response to vitamin D. Pregnant or lactating females. Hepatic patients. Renal patients. Patients with bleeding tendency.

研究组 & 干预措施

Cholecalciferol injection

Experimental

干预措施: Cholecalciferol (Drug)

结局指标

主要结局

Resolution of verrucae

时间窗: 3 months

Decrease of verrucae size Decrease of verrucae number

次要结局

  • Involucrin expression(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Essam Mohamed El-sayed Akl

Assistant Professor

Benha University

研究点 (1)

Loading locations...

相似试验